文献速递角膜与眼表疾病

经上皮与去上皮角膜交联治疗进展性圆锥角膜:Cochrane系统综述

Transepithelial Versus Epithelium-Off Corneal Crosslinking for Progressive Keratoconus: Findings From a Cochrane Systematic Review.
PubMed 文献 · Am J Ophthalmol · 2021-05-25

5项RCT(177眼)的Meta分析显示,术后12个月或更晚的最大角膜曲率(Kmax)平均差异为0.99D(95%CI:-0.11至2.09),两组间无差异。由于样本量小、偏倚风险不明确及结局报告不一致,现有数据难以确定经上皮CXL是否优于去上皮CXL。

要点

  • 经上皮与去上皮CXL在12个月或更晚的Kmax变化无显著差异(MD 0.99D,95%CI -0.11至2.09)。
  • 证据受限于小样本、偏倚风险不明确及结局测量报告不一致。
  • 基于现有数据,无法确定经上皮CXL在圆锥角膜稳定、视力或患者报告结局方面优于去上皮CXL。

核心结论

  • 基于现有数据,难以确定经上皮CXL在圆锥角膜稳定、视力或患者报告结局方面是否优于去上皮CXL。

研究设计与样本

  • Cochrane系统综述,仅纳入比较经上皮与去上皮CXL治疗进展性圆锥角膜的随机对照试验。

主要发现

  • 2项研究报告了圆锥角膜稳定作为结局。
  • 5项RCT(177眼)的Meta分析显示,术后12个月或更晚Kmax平均差异为0.99D(95%CI:-0.11至2.09),组间无差异。
  • 2项比较离子导入经上皮CXL的研究在术后12个月或更晚的角膜曲率和视力结局Meta分析未提供优于去上皮CXL的确凿证据。

关键数值与推荐

  • 主要结局为基于术后最大角膜曲率(Kmax)的圆锥角膜稳定。
  • Kmax平均差异(MD)为0.99D(95%CI:-0.11至2.09),来自5项RCT共177眼的Meta分析,随访12个月或更晚。

临床怎么用

  • 临床决策时需认识到经上皮CXL与去上皮CXL相比缺乏明确优势证据。
  • 应结合患者具体情况和现有证据的不确定性选择术式。

局限性

  • 样本量小导致精确性不足。
  • 报告不充分导致偏倚风险不明确。
  • 研究间结局测量和报告不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to summarize key findings from a systematic review of the effectiveness and safety of transepithelial corneal crosslinking (CXL) compared with epithelium-off CXL for progressive keratoconus. DESIGN: Cochrane systematic review. METHODS: We included in our review only randomized controlled trials (RCTs) in which transepithelial and epithelium-off CXL had been compared among participants with progressive keratoconus. The primary outcome was keratoconus stabilization based on post-operative maximum keratometry (Kmax). We adhered to Cochrane methods for trial selection, data extraction, risk of bias evaluation, and data synthesis. RESULTS: Thirteen RCTs with 567 participants (661 eyes) were included; 11 studies compared non-iontophoresis-assisted transepithelial with epithelium-off CXL. Keratoconus stabilization was described as an outcome in 2 studies. The estimated difference in Kmax means (ie, the "mean difference," MD) from meta-analysis of 177 eyes in 5 RCTs indicated that there were no differences between intervention groups in Kmax at 12 months or later (MD: 0.99 diopter [D]; 95% confidence interval: -0.11 to 2.09). Meta-analysis of keratometry and visual acuity outcomes at 12 months or longer after surgery from 2 studies that had compared transepithelial CXL using iontophoresis provided no conclusive evidence of an advantage over epithelium-off CXL. CONCLUSIONS: Lack of precision due to small sample sizes, indeterminate risk of bias due to inadequate reporting, and inconsistency in how outcomes were measured and reported among studies make it difficult to state with confidence whether transepithelial CXL confers an advantage over epithelium-off CXL for patients with progressive keratoconus with respect to stabilization of keratoconus, visual acuity, or patient-reported outcomes based on available data.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Ng SM, Hawkins BS, Kuo IC, et al. Transepithelial Versus Epithelium-Off Corneal Crosslinking for Progressive Keratoconus: Findings From a Cochrane Systematic Review. Am J Ophthalmol. 2021. PMID: 34048801. doi:10.1016/j.ajo.2021.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。